Breaking News Instant updates and real-time market news.

AOBC

American Outdoor Brands

$9.17

0.13 (1.44%)

, ORCL

Oracle

$52.69

-0.19 (-0.36%)

18:44
06/19/19
06/19
18:44
06/19/19
18:44

Fly Intel: After Hours Movers

UP AFTER EARNINGS: American Outdoor Brands (AOBC) up 6.7%... Oracle Corp (ORCL) up 4.9%. ALSO HIGHER: Jensyn Acquisition (JSYN) up 185% after shareholder approval of Peck Electric combination... Abeona Therapeutics (ABEO) up 2.3% after receiving FDA Fast Track designation for ABO-202 program. DOWN AFTER EARNINGS: Pier 1 Imports (PIR) down 14.5% after announcing 1-for-20 reverse stock split... Steelcase (SCS) down 10.2%. ALSO LOWER: Gladstone Land (LAND) down 3.9% after equity offering. Movers as of 18:30ET.

AOBC

American Outdoor Brands

$9.17

0.13 (1.44%)

ORCL

Oracle

$52.69

-0.19 (-0.36%)

JSYN

Jensyn Acquisition

$5.00

-5.02 (-50.10%)

ABEO

Abeona Therapeutics

$4.90

-0.09 (-1.80%)

PIR

Pier 1 Imports

$0.67

-0.0059 (-0.87%)

SCS

Steelcase

$17.80

0.235 (1.34%)

LAND

Gladstone Land

$12.29

0.39 (3.28%)

  • 19

    Jun

  • 19

    Jun

  • 19

    Jun

  • 20

    Jun

  • 24

    Jun

  • 26

    Jun

  • 26

    Jun

  • 10

    Jul

  • 20

    Jun

AOBC American Outdoor Brands
$9.17

0.13 (1.44%)

03/13/19
03/13/19
DOWNGRADE
Target $11

Neutral
American Outdoor Brands downgraded to Neutral at Wedbush
As previously reported, Wedbush analyst James Hardiman downgraded American Outdoor Brands to Neutral from Outperform given unfavorable near-term catalysts. Following significantly better-than-expected results so far this year, the analyst believes the selloff in the shares has been overdone especially given the opportunity for the company to manufacture growth in FY20 independent of a major rebound in demand. However, Hardiman believes the near-term outlook, which includes the toughest comps of the Trump era and a hazardous FY20 guide, is more likely to further spook investors than to bring them onboard. He also lowered his price target on the shares to $11 from $13.50.
03/13/19
WEDB
03/13/19
DOWNGRADE
WEDB
Neutral
American Outdoor Brands downgraded to Neutral from Outperform at Wedbush
11/01/18
11/01/18
DOWNGRADE
Target $13

Hold
American Outdoor Brands downgraded to Hold on soft demand at Craig-Hallum
As previously reported, Craig-Hallum analyst Steve Dyer downgraded American Outdoor Brands to Hold from Buy as his checks indicate firearm demand has remained "stubbornly soft" through important seasonal selling season. The analyst also lowered his price target on the shares to $13 from $15.
11/01/18
CHLM
11/01/18
DOWNGRADE
CHLM
Hold
American Outdoor Brands downgraded to Hold from Buy at Craig-Hallum
ORCL Oracle
$52.69

-0.19 (-0.36%)

06/18/19
MACQ
06/18/19
DOWNGRADE
Target $55
MACQ
Neutral
Macquarie downgrades Oracle to Neutral, says partners suggest softening
As previously reported, Macquarie downgraded Oracle to Neutral from Outperform, with analyst Sarah Hindlian telling investors that her checks suggest that closing the fourth quarter "was a struggle," with partners saying they had to rush to discount orders up until the final days. Several leading partners saw softening of the pipeline and she believes "there is a step function lower" in demand for Oracle, the analyst said. While she sees several potential tailwinds for Oracle in FY20 - including less marketing spending, improving uptake of Cloud ERP, increased prices on support and adoption of 18c/autonomous DB - she also thinks outperformance will be capped because the company is struggling to execute on its strategy. Hindlian has a $55 price target on Oracle shares.
06/13/19
OTRG
06/13/19
UPGRADE
OTRG
Mixed
Oracle upgraded to Mixed from Negative at OTR Global
06/18/19
MACQ
06/18/19
DOWNGRADE
MACQ
Neutral
Oracle downgraded to Neutral from Outperform at Macquarie
06/18/19
06/18/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. InterContinental (IHG) downgraded to Underweight from Equal Weight at Barclays with analyst Vicki Stern stating downside risks from a macroeconomic slowdown are not reflected in the stock at current valuation levels. 2. Freshpet (FRPT) downgraded to Hold from Buy at SunTrust with analyst William Chappell saying his positive view of the company's fundamental story and outlook have not changed, but he cannot recommend for new investors to buy the stock at its current levels. 3. Regeneron (REGN) downgraded to Hold from Buy at Argus with analyst Jasper Hellweg noting that while the company has a "strong pipeline" with new recent indications for multiple products, its primary revenue driver Eylea is facing several competitive threats. 4. Oracle (ORCL) downgraded to Neutral from Outperform at Macquarie with analyst Sarah Hindlian telling investors that her checks suggest that closing the fourth quarter "was a struggle," with partners saying they had to rush to discount orders up until the final days. 5. J.B. Hunt (JBHT) downgraded to Neutral from Buy at UBS with analyst Thomas Wadewitz citing his increasing conviction that after a period of strong freight and unusually strong pricing in 2018, the downturn in freight will persist through 2019 amid "falling truckload and intermodal contract rates" for 2020. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
JSYN Jensyn Acquisition
$5.00

-5.02 (-50.10%)

ABEO Abeona Therapeutics
$4.90

-0.09 (-1.80%)

11/27/18
RBCM
11/27/18
NO CHANGE
RBCM
Outperform
Abeona Therapeutics' CEO dismissal not reflective of execution, says RBC Capital
RBC Capital analyst Kennen MacKay kept his Outperform rating on Abeona Therapeutics, saying that while the dismissal of the company's CEO following allegations of professional misconduct were surprising, they do not reflect the company's "corporate, operational, or clinical execution". The analyst believes that the interim CEO, Dr. Siffert, is well-equipped to lead Abeona Therapeutics' operational and R&D activities, having served previously on the board of AveXis, which is "another gene therapy pioneer."
11/27/18
MZHO
11/27/18
NO CHANGE
Target $17
MZHO
Buy
Abeona clinical programs on track despite CEO termination, says Mizuho
Mizuho analyst Difei Yang spoke to Abeona Therapeutics after the company announced the termination of CEO Carsten Thiel for personal misconduct. All of Abeona's clinical development programs remain on track and the analyst says she was assured the termination is not related to operational/business matters. Yang keeps a Buy rating on Abeona with a $17 price target following the "unexpected" CEO termination.
10/12/18
10/12/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Comcast (CMCSA) reinstated with an Overweight at JPMorgan. 2. Abeona Therapeutics (ABEO) initiated with a Buy at Mizuho. 3. Foamix (FOMX) initiated with an Overweight at Cantor Fitzgerald. 4. Match Group (MTCH) and IAC (IAC) were initiated with a Buy at Nomura Instinet while Angi Homeservices (ANGI) was initiated with a Neutral at Nomura Instinet. 5. Terex (TEX) initiated with a Neutral at Longbow. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/12/18
MZHO
10/12/18
INITIATION
Target $17
MZHO
Buy
Mizuho starts Abeona Therapeutics with Buy rating, $17 price target
Mizuho analyst Difei Yang last night initiated coverage of Abeona Therapeutics with a Buy rating and $17 price target. With two indications progressing towards phase 3 pivotal trials, Abeona is well positioned to address unmet needs in two rare diseases, Yang tells investors in a research note. She believes EB-101 for the treatment of recessive dystrophic epidermolysis bullosa has shown encouraging results in Phase 1/2 trials and that ABO-102 for the treatment of Sanfilippo syndrome Type A shows promise with early positive biomarker data.
PIR Pier 1 Imports
$0.67

-0.0059 (-0.87%)

01/08/19
GDHS
01/08/19
UPGRADE
GDHS
Hold
Pier 1 Imports upgraded to Hold from Underperform at Gordon Haskett
03/21/19
GDHS
03/21/19
DOWNGRADE
GDHS
Underperform
Pier 1 Imports downgraded to Underperform at Gordon Haskett
03/21/19
GDHS
03/21/19
NO CHANGE
GDHS
Gordon Haskett shakes up retailer rankings with six upgrades, three downgrades
Gordon Haskett analysts Chuck Grom, John Park and Andrew Minora have recalibrated their ratings in broadline and hardline retail with the Q4 earnings season nearly complete, stating that holiday results were mixed with clear winners and losers and that year-to-date sales have been "extremely choppy." The firm's latest macro/consumer survey results suggest that some optimism has resurfaced and they see a scenario where there is a release of significant pent-up demand for the retail group. Within the context of a portfolio approach to the space, the analysts upgraded Target (TGT), Tractor Supply (TSCO), Dollar Tree (DLTR), BJ's Wholesale (BJ) to Buy from Accumulate, upgraded Wayfair (W) and Floor & Decor (FND) to Accumulate from Hold, and downgrade Nordstrom (JWN) and Sprouts Farmers Market (SFM) to Reduce from Hold. The analysts also downgraded Pier 1 Imports (PIR) to Underperform from Hold.
04/24/19
MSCO
04/24/19
NO CHANGE
Target $30
MSCO
Overweight
At Home could double market share, triple sales by 2028, says Morgan Stanley
Morgan Stanley analyst Simeon Gutman said he believes At Home Group (HOME) can drive meaningful share gains with its superior value proposition of the lowest prices, a wide assortment and high levels of in-stock inventory. Over the next ten years, he estimates At Home could double its market share and triple its revenue, highlighting Pier 1 Imports (PIR) as one of "many" potential share donor, stating that his analysis suggests At Home could capture greater than $110M in sales from Pier 1 over the next ten years. Gutman keeps an Overweight rating and $30 price target on At Home shares.
SCS Steelcase
$17.80

0.235 (1.34%)

03/21/19
RAJA
03/21/19
UPGRADE
RAJA
Strong Buy
Steelcase upgraded to Strong Buy from Outperform at Raymond James
03/21/19
03/21/19
UPGRADE

Strong Buy
Steelcase upgraded to Strong Buy, shares 'on sale,' says Raymond James
As previously reported, Raymond James upgraded Steelcase to Strong Buy from Outperform and increased its price target to $21 from $20. Analyst Budd Bugatch said the 14% share drop yesterday following solid Q4 results is "puzzling" and said shares are "on sale."
10/12/18
GHSC
10/12/18
UPGRADE
Target $20
GHSC
Buy
Steelcase upgraded to Buy from Neutral at Seaport Global
Seaport Global analyst Matt McCall upgraded Steelcase to Buy from Neutral with a $20 price target citing cyclical, secular, and company specific opportunities. McCall said a "perfect storm" is setting-up from continued top-line momentum in commercial, minimal impact from tariffs and positive impact from the USMCA trade agreement, EMEA demand, several more quarters of easy comps, and reasonable valuation.
LAND Gladstone Land
$12.29

0.39 (3.28%)

01/14/19
JMPS
01/14/19
DOWNGRADE
JMPS
Underperform
Gladstone Land downgraded to Underperform from Market Perform at JMP Securities
01/14/19
01/14/19
DOWNGRADE
Target $9.5

Underperform
JMP Securities says Gladstone Land overvalued, downgrades to Underperform
As previously reported, JMP Securities analyst Peter Martin downgraded Gladstone Land to Underperform from Market Perform, stating that he believes the stock deserves a 15% discount to his estimate of its net asset value given its leverage, which is "north of 65% net debt to cap," and a dividend payout ratio that is over 100% of his estimate of participation fee revenue. However, the stock currently trades at about a 15% premium to his NAV, which Martin said he is "hard pressed to understand" given what he views as its limited growth prospects, its dividend coverage ratio and the fact that 24% of NOI is maturing in 2020. He set a $9.50 price target on Gladstone Land shares.

TODAY'S FREE FLY STORIES

FNV

Franco-Nevada

$89.61

2.02 (2.31%)

09:08
07/19/19
07/19
09:08
07/19/19
09:08
Hot Stocks
Franco-Nevada initiates ATM equity program fo up to $200M »

Franco-Nevada has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLWPF

Flowr

$0.00

(0.00%)

09:08
07/19/19
07/19
09:08
07/19/19
09:08
Syndicate
Flowr withdraws equity offering due to market conditions »

The Flowr Corporation has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

RRC

Range Resources

$5.14

-0.09 (-1.72%)

09:07
07/19/19
07/19
09:07
07/19/19
09:07
Hot Stocks
Range Resources announces assets sales to total $634M »

RANGE RESOURCES announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 13

    Aug

FNV

Franco-Nevada

$89.61

2.02 (2.31%)

, RRC

Range Resources

$5.14

-0.09 (-1.72%)

09:07
07/19/19
07/19
09:07
07/19/19
09:07
Hot Stocks
Franco-Nevada acquires Marcellus Shale interest from Range Resources for $300M »

Franco-Nevada (FNV) has…

FNV

Franco-Nevada

$89.61

2.02 (2.31%)

RRC

Range Resources

$5.14

-0.09 (-1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 13

    Aug

DISH

Dish

$40.82

-0.04 (-0.10%)

09:06
07/19/19
07/19
09:06
07/19/19
09:06
Hot Stocks
Dish names Kannan Alagappan as Chief Technology Officer »

Dish announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACU

Acme United

$19.95

0.45 (2.31%)

09:05
07/19/19
07/19
09:05
07/19/19
09:05
Earnings
Acme United backs FY19 EPS guidance $1.41-$1.50, two est. $1.46 »

CEO Walter Johnsen said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

ISRG

Intuitive Surgical

$536.44

13.25 (2.53%)

09:04
07/19/19
07/19
09:04
07/19/19
09:04
Recommendations
Intuitive Surgical analyst commentary  »

Consensus view of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 09

    Sep

WNS

WNS Holdings

$62.34

3.8 (6.49%)

09:03
07/19/19
07/19
09:03
07/19/19
09:03
Recommendations
WNS Holdings analyst commentary  »

WNS Holdings price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Aug

ACU

Acme United

$19.95

0.45 (2.31%)

09:03
07/19/19
07/19
09:03
07/19/19
09:03
Earnings
Acme United reports Q2 EPS 77c, two est. 75c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

NVR

NVR

$3,486.00

-20.17 (-0.58%)

09:01
07/19/19
07/19
09:01
07/19/19
09:01
Earnings
NVR reports Q2 EPS $53.09, consensus $44.82 »

Reports Q2 revenue $1.8B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

UBER

Uber

$43.70

0.08 (0.18%)

09:00
07/19/19
07/19
09:00
07/19/19
09:00
Periodicals
Uber raising prices on Jump dockless electric bikes, Business Insider reports »

Uber is raising prices on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

SKX

Skechers

$34.75

0.35 (1.02%)

08:59
07/19/19
07/19
08:59
07/19/19
08:59
Upgrade
Skechers rating change  »

Skechers upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLB

Schlumberger

$38.78

0.15 (0.39%)

08:58
07/19/19
07/19
08:58
07/19/19
08:58
Hot Stocks
Breaking Hot Stocks news story on Schlumberger »

Schlumberger's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Aug

  • 13

    Nov

SLB

Schlumberger

$38.78

0.15 (0.39%)

08:56
07/19/19
07/19
08:56
07/19/19
08:56
Hot Stocks
Schlumberger says North America land 'remains a challenging environment' »

Says: Continues to see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Aug

  • 13

    Nov

UNP

Union Pacific

$174.15

10.1 (6.16%)

08:56
07/19/19
07/19
08:56
07/19/19
08:56
Recommendations
Union Pacific analyst commentary at Morgan Stanley »

Morgan Stanley stays…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

MSFT

Microsoft

$136.29

0.06 (0.04%)

, NFLX

Netflix

$325.14

-37.36 (-10.31%)

08:55
07/19/19
07/19
08:55
07/19/19
08:55
Options
Notable open interest changes for July 19th »

Thursday's total…

MSFT

Microsoft

$136.29

0.06 (0.04%)

NFLX

Netflix

$325.14

-37.36 (-10.31%)

CMCSA

Comcast

$44.56

0.13 (0.29%)

MNST

Monster Beverage

$64.96

-0.77 (-1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

  • 08

    Aug

NFLX

Netflix

$325.14

-37.36 (-10.31%)

, DIS

Disney

$141.62

-0.97 (-0.68%)

08:54
07/19/19
07/19
08:54
07/19/19
08:54
Recommendations
Netflix, Disney analyst commentary  »

Netflix sub losses are…

NFLX

Netflix

$325.14

-37.36 (-10.31%)

DIS

Disney

$141.62

-0.97 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

DB

Deutsche Bank

$7.93

0.05 (0.63%)

08:47
07/19/19
07/19
08:47
07/19/19
08:47
Conference/Events
Deutsche Bank to hold a conference call »

Management holds the 2Q19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 26

    Jul

SPY

SPDR S&P 500 ETF Trust

$298.86

1.07 (0.36%)

, SPX

S&P 500

$0.00

(0.00%)

08:46
07/19/19
07/19
08:46
07/19/19
08:46
General news
Trump says Federal Reserve thought process 'faulty' »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$298.86

1.07 (0.36%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$6.44

-0.12 (-1.83%)

, BZUN

Baozun

$50.05

0.05 (0.10%)

08:45
07/19/19
07/19
08:45
07/19/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

APHA

Aphria

$6.44

-0.12 (-1.83%)

BZUN

Baozun

$50.05

0.05 (0.10%)

CGC

Canopy Growth

$35.79

-0.78 (-2.13%)

UBER

Uber

$43.70

0.08 (0.18%)

PETS

PetMed Express

$16.27

-0.68 (-4.01%)

LK

Luckin Coffee

$19.96

0.46 (2.36%)

ESTC

Elastic

$97.78

1.82 (1.90%)

TECK

Teck Resources

$22.01

-0.21 (-0.95%)

DUST

Direxion Daily Gold Miners Bear 3X ETF

$8.06

-1.2 (-12.96%)

DDS

Dillard's

$64.05

-0.3 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 25

    Jul

  • 26

    Jul

  • 01

    Aug

  • 08

    Aug

YGYI

Youngevity

$4.97

-0.22 (-4.24%)

08:40
07/19/19
07/19
08:40
07/19/19
08:40
Hot Stocks
Youngevity's Khrysos Industries closes $19M supply agreement »

Youngevity executed a one…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$71.79

0.95 (1.34%)

08:38
07/19/19
07/19
08:38
07/19/19
08:38
Conference/Events
Citi to host conference call »

CFO Mason & Treasurer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 15

    Oct

SYDDF

Sydney Airport

$0.00

(0.00%)

08:37
07/19/19
07/19
08:37
07/19/19
08:37
Initiation
Sydney Airport initiated at JPMorgan »

Sydney Airport initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEAS

SeaWorld

$33.81

0.38 (1.14%)

08:37
07/19/19
07/19
08:37
07/19/19
08:37
Hot Stocks
SeaWorld elects Charles Koppelman as director, announces board changes »

SeaWorld's Board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

GILD

Gilead

$67.22

0.31 (0.46%)

, NVS

Novartis

$94.30

4.185 (4.64%)

08:37
07/19/19
07/19
08:37
07/19/19
08:37
Hot Stocks
Gilead licenses three preclinical antiviral programs from Novartis »

Gilead (GILD) announced…

GILD

Gilead

$67.22

0.31 (0.46%)

NVS

Novartis

$94.30

4.185 (4.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 22

    Jul

  • 23

    Jul

  • 30

    Jul

  • 07

    Aug

  • 09

    Sep

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.